Morales NP - Search Results

1

Pharmaco/ferrokinetic-related pro-oxidant activity of deferiprone in beta-thalassemia.

Jirasomprasert T, Morales NP, Limenta LM, Sirijaroonwong S, Yamanont P, Wilairat P, Fucharoen S, Chantharaksri U. Jirasomprasert T, et al. Among authors: morales np. Free Radic Res. 2009 May;43(5):485-91. doi: 10.1080/10715760902870611. Free Radic Res. 2009. PMID: 19353420

2

The reduction of cholesteryl linoleate in lipoproteins: an index of clinical severity in beta-thalassemia/Hb E.

Luechapudiporn R, Morales NP, Fucharoen S, Chantharaksri U. Luechapudiporn R, et al. Among authors: morales np. Clin Chem Lab Med. 2006;44(5):574-81. doi: 10.1515/CCLM.2006.093. Clin Chem Lab Med. 2006. PMID: 16681427

3

A pharmacokinetic study of paracetamol in Thai beta-thalassemia/HbE patients.

Tankanitlert J, Howard TA, Temsakulphong A, Sirankapracha P, Morales NP, Sanvarinda Y, Fucharoen P, Ware RE, Fucharoen S, Chantharaksri U. Tankanitlert J, et al. Among authors: morales np. Eur J Clin Pharmacol. 2006 Sep;62(9):743-8. doi: 10.1007/s00228-006-0167-2. Epub 2006 Jul 15. Eur J Clin Pharmacol. 2006. PMID: 16845508

4

Lipid fluidity at different regions in LDL and HDL of beta-thalassemia/Hb E patients.

Morales NP, Charlermchoung C, Luechapudiporn R, Yamanont P, Fucharoen S, Chantharaksri U. Morales NP, et al. Biochem Biophys Res Commun. 2006 Nov 24;350(3):698-703. doi: 10.1016/j.bbrc.2006.09.106. Epub 2006 Sep 28. Biochem Biophys Res Commun. 2006. PMID: 17027920

5

Effects of combined UDP-glucuronosyltransferase (UGT) 1A1*28 and 1A6*2 on paracetamol pharmacokinetics in beta-thalassemia/HbE.

Tankanitlert J, Morales NP, Howard TA, Fucharoen P, Ware RE, Fucharoen S, Chantharaksri U. Tankanitlert J, et al. Among authors: morales np. Pharmacology. 2007;79(2):97-103. doi: 10.1159/000097908. Epub 2006 Dec 12. Pharmacology. 2007. PMID: 17164591

6

Association between promoter and coding region mutations of UDP-glucuronosyltransferase 1A1 and beta-thalassemia/Hb E with cholelithiasis.

Tankanitlert J, Morales NP, Fucharoen P, Fucharoen S, Chantharaksri U. Tankanitlert J, et al. Among authors: morales np. Eur J Haematol. 2008 Apr;80(4):351-5. doi: 10.1111/j.1600-0609.2007.01010.x. Epub 2007 Dec 10. Eur J Haematol. 2008. PMID: 18081723

7

UGT1A6 genotype-related pharmacokinetics of deferiprone (L1) in healthy volunteers.

Limenta LM, Jirasomprasert T, Tankanitlert J, Svasti S, Wilairat P, Chantharaksri U, Fucharoen S, Morales NP. Limenta LM, et al. Among authors: morales np. Br J Clin Pharmacol. 2008 Jun;65(6):908-16. doi: 10.1111/j.1365-2125.2008.03103.x. Epub 2008 Mar 3. Br J Clin Pharmacol. 2008. PMID: 18318774 Free PMC article.

8

Bioequivalence study of a film-coated tablet of deferiprone in healthy Thai volunteers.

Morales NP, L, Yamanont P, Jirasomprasert T, Wilairat P, Chantharaksri U, Chuncharunee S, Fucharoen S. Morales NP, et al. Int J Clin Pharmacol Ther. 2009 May;47(5):358-64. doi: 10.5414/cpp47358. Int J Clin Pharmacol Ther. 2009. PMID: 19473596 Clinical Trial.

9

Pharmacokinetics of deferiprone in patients with β-thalassaemia: impact of splenectomy and iron status.

Limenta LM, Jirasomprasert T, Jittangprasert P, Wilairat P, Yamanont P, Chantharaksri U, Fucharoen S, Morales NP. Limenta LM, et al. Among authors: morales np. Clin Pharmacokinet. 2011 Jan;50(1):41-50. doi: 10.2165/11536630-000000000-00000. Clin Pharmacokinet. 2011. PMID: 21028920

10

Vitamin E supplement improves erythrocyte membrane fluidity of thalassemia: an ESR spin labeling study.

Sutipornpalangkul W, Morales NP, Unchern S, Sanvarinda Y, Chantharaksri U, Fucharoen S. Sutipornpalangkul W, et al. Among authors: morales np. J Med Assoc Thai. 2012 Jan;95(1):29-36. J Med Assoc Thai. 2012. PMID: 22379738 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

63 results

Search Page